From the 2015 Conferences to the Clinic
Program Goals
A Double-Blind, Randomized, Placebo-Controlled, Flexible-Dose Study of Vilazodone in Patients With GAD
Vilazodone-GAD Randomized Controlled Trial Results Efficacy
Vilazodone-GAD Randomized Controlled Trial Improvement in Functional Domains
From the 2015 Conferences to the Clinic
Post hoc Analyses of Suicidality in Clinical Trials of Vilazodone
Suicidality in Vilazodone Clinical Trials
Levomilnacipran ER Treatment in Adult Patients With First-Episode, Highly Recurrent, and Chronic MDD
Levomilnacipran ER
Efficacy of Vortioxetine in the Treatment of Patients With MDD in Short-term Placebo-Controlled Studies: A Meta-analysis of 11 Studies
Efficacy of Vortioxetine Results
From the 2015 Conferences to the Clinic
Lurasidone for the Treatment of MDD With Mixed Features A Randomized, Double-Blind, Placebo-Controlled, 6-Wk Trial
Lurasidone for the Treatment of MDD With Mixed Features A Randomized, Double-Blind, Placebo-Controlled, 6-Wk Trial (cont)
Patterns of Antidepressant Efficacy With Quetiapine ER as Adjunct to Different Ongoing Antidepressants: Exploration of MOA Hypotheses
Patterns of Antidepressant Efficacy With Quetiapine ER as Adjunct to Different Ongoing Antidepressants: Exploration of MOA Hypotheses (cont)
Efficacy and Safety of Cariprazine as Adjunctive Therapy in MDD A Double-Blind, Randomized, Placebo-Controlled Study
From the 2015 Conferences to the Clinic
Metabolic Tolerability Profile of Adjunct Brexpiprazole (OPC-34712) in MDD Study Design
Metabolic Tolerability Profile Results
Metabolic Tolerability Profile Results (cont)
Efficacy and Safety of Brexpiprazole (OPC-34712) as Adjunctive Treatment in MDD Pooled Analysis of 2 Pivotal Studies
Efficacy and Safety of Brexpiprazole Results
Abbreviations
Abbreviations (cont)
References
References (cont)
References (cont)